A novel combination of CDK4/6 and PI3K inhibitors exhibits highly synergistic activity and translational potential in Ewing sarcoma
Maria Ana Isabel C. De Los Santos(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Brian D. Crompton(Dana-Farber/Boston Children's Cancer and Blood Disorders Center)
Cited by 0
Related Papers
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer
|Nature Medicine|2022|65